Your browser doesn't support javascript.
Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.
Krause, Eva; Puyskens, Andreas; Bourquain, Daniel; Brinkmann, Annika; Biere, Barbara; Schaade, Lars; Michel, Janine; Nitsche, Andreas.
  • Krause E; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Puyskens A; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Bourquain D; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Brinkmann A; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Biere B; Influenza and Other Respiratory Viruses (FG 17), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Schaade L; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Michel J; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
  • Nitsche A; Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany. Electronic address: NitscheA@rki.de.
Mol Cell Probes ; 58: 101742, 2021 08.
Article in English | MEDLINE | ID: covidwho-1220955
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Point of care detection of SARS-CoV-2 is one pillar in a containment strategy and important to break infection chains. Here we report the sensitive, specific and robust detection of SARS-CoV-2 and respective variants of concern by the ID NOW COVID-19 device.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Point-of-Care Systems / Molecular Diagnostic Techniques / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Variants Limits: Humans Language: English Journal: Mol Cell Probes Journal subject: Molecular Biology / Biotechnology Year: 2021 Document Type: Article Affiliation country: J.mcp.2021.101742

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Point-of-Care Systems / Molecular Diagnostic Techniques / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Variants Limits: Humans Language: English Journal: Mol Cell Probes Journal subject: Molecular Biology / Biotechnology Year: 2021 Document Type: Article Affiliation country: J.mcp.2021.101742